Browser storage is unavailable. Keep this page open and export your collection before leaving.
Biotech pharma

Felix Biotechnology
Overview
We are building the first end-to-end digital viral design platform to protect the world against the coming threat of antimicrobial resistance.
Company description As recorded 2026-11-08
Founders & team
Founder profile As recorded 2026-09-15
Vivek Mutalik
FounderFounder profile As recorded 2026-09-15
Paul Turner
FounderFounder profile As recorded 2026-09-15
6team members reported
Source-reported As recorded 2026-09-15
Founded 2019 · Source
News & product activity
Cohort membership
Winter 2020Winter 2020
Original evidence ↗Sources & observations
Profile depthenriched profile
Website observationwebsite unreachable
Last website check2026-11-11
Location · source statedSan Francisco, CA, USA
Pricing evidenceA pricing page was detected
Maturity: Not assessed · 4 of 6 areas documented
Source-based assessment · automated evidence rules
The source reports an inactive or acquired company; current product identity needs review.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.
- Product overviewSource description Checked 2026-11-08
- Product visualsNot documented
- Founders & originsTeam information
- Business model & pricingPricing page detected on company website; plans not reviewed Checked 2026-09-15
- Funding & ownershipNot documented
- Dated milestonesDated source activity: 2020 Q1 (quarter only)
independent websitesource corroborationdescriptive evidenceclassified market and modelsourced peoplesourced founding yearpricing page observed





